Skip to main content
TipRanks
Go Ultimate75% OFF

Medtronic (MDT) Stock Price & Analysis

6,694 Followers

MDT Stock Chart & Stats

$102.86$1.87(1.85%)
At close: 4:00 PM EST
$90$100Aug 17Aug 31Sep 14Sep 28Oct 12Oct 26Nov 9
Day’s Range
$101.41 - $103.34
52-Week Range
$73.31 - $106.33
Previous Close
$100.99
Volume
N/A
Average Volume (3M)
22.19M
Market Cap
$131.58B
Enterprise Value
$129.69B
Total Cash (Recent Filing)
$8.82B
Total Debt (Recent Filing)
$28.15B
Price to Earnings (P/E)
25.1
Beta
0.29
Next Earnings
Nov 24, 2026 (Est.)
Dividend Yield
2.78%

Bulls Say, Bears Say

Bulls Say

Broad-based Portfolio Growth

Growth across multiple operating units, regions and procedure volumes reduces reliance on any single therapy or market. This breadth supports more durable revenue expansion, gives successful products room to scale, and strengthens Medtronic’s ability to sustain performance through differing healthcare demand cycles.

Strong Cash Generation And Margins

Improving operating profitability alongside rising free cash flow gives Medtronic meaningful internal funding capacity. Strong cash generation can support research, acquisitions, debt service and shareholder returns, while the margin improvement indicates that recent growth is translating into better earnings quality.

Portfolio Simplification And Strategic Focus

Separating MiniMed and simplifying the product portfolio should allow management to focus resources on core cardiovascular, neuroscience and surgical platforms. SKU rationalization can also reduce complexity and improve execution, creating a clearer strategic base for innovation and operating leverage.

Bears Say

Elevated Debt And Leverage

Although equity supports a moderate leverage profile, the elevated absolute debt balance can reduce financial flexibility if growth slows or capital costs rise. Debt service and refinancing requirements may compete with investment in innovation, acquisitions and shareholder distributions over the medium term.

Neuromodulation Market Softness

Weakness in spinal cord stimulation and replacement demand creates a persistent drag within the neuroscience portfolio. If these conditions continue, they could limit segment growth, dilute the benefit of stronger newer products, and require additional investment to restore momentum and defend market position.

Structural Heart Underperformance

Low-single-digit Structural Heart growth indicates that an important cardiovascular category is expanding more slowly than several of Medtronic’s faster-growing businesses. Stable procedure volumes and slower portfolio momentum could constrain mix improvement and limit the segment’s contribution to overall growth.

Medtronic News

MDT FAQ

What was Medtronic’s price range in the past 12 months?
Medtronic lowest stock price was $73.31 and its highest was $106.33 in the past 12 months.
What is Medtronic’s market cap?
Medtronic’s market cap is $131.58B.
When is Medtronic’s upcoming earnings report date?
Medtronic’s next earnings report is estimated for Nov 24, 2026 (not yet confirmed), which is in 9 days.
How were Medtronic’s earnings last quarter?
Medtronic released its earnings results on Sep 01, 2026. The company reported $1.45 earnings per share for the quarter, beating the consensus estimate of $1.388 by $0.062.
Is Medtronic overvalued?
According to Wall Street analysts Medtronic’s price is currently Undervalued.
Does Medtronic pay dividends?
Medtronic pays a quarterly dividend of $0.72 which represents an annual dividend yield of 2.78%. See more information on Medtronic dividends here
What is Medtronic’s EPS estimate?
Medtronic’s EPS estimate is 1.33.
How many shares outstanding does Medtronic have?
Medtronic has 1,279,169,900 shares outstanding.
What happened to Medtronic’s price movement after its last earnings report?
Medtronic reported an EPS of $1.45 in its last earnings report, beating expectations of $1.388. Following the earnings report the stock price went up 1.534%.
Which hedge fund is a major shareholder of Medtronic?
Hedge funds hold Medtronic shares: the largest hedge-fund position in Medtronic is 72,325,796 shares, and hedge funds increased their holdings by 5.5M shares last quarter.
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology